bpc-157 peptide human clinical trial Frontiers BPC-157 Peptide – Tissue Repair
Description
No fragrances
A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury
doi: 10.1111/j.1468-1293.2010.00906.x
The peptides mechanism appears to preferentially mobilize fat from metabolically active depots while preserving muscle tissue, creating favorable body recomposition rather than non-selective weight loss
